Loading Page
Dr. Frederick J. Kaskel, MD, PhD is a pediatric nephrologist in Bronx, NY specializing in pediatric nephrology. He graduated from University of Cincinnati College of Medicine. Dr. Frederick J. Kaskel, MD, PhD is affiliated with Children's Hospital at Montefiore (CHAM), Montefiore Einstein, White Plains Hospital and MONTEFIORE MEDICAL CENTER.
Dr. Frederick J. Kaskel, MD, PhD graduated from University of Cincinnati College of Medicine. He completed residency at Montefiore Medical Center. He is certified by the American Board of Pediatrics: Pediatric Nephrology and has a state license in New York.
Medical School: University of Cincinnati College of Medicine
Residency: Montefiore Medical Center
Board Certification: American Board of Pediatrics: Pediatric Nephrology
Licensed In: New York
Dr. Frederick J. Kaskel, MD, PhD appears to accept the following insurance providers: Aetna, Anthem, Affinity Health Plan, Show more, Amidacare, 1199SEIU Benefit Funds, CDPHP and ArchCare.
According to our sources, Dr. Frederick J. Kaskel, MD, PhD accepts the following insurance providers:
Dr. Frederick J. Kaskel, MD, PhD does not have any reviews yet, be the first to leave a review of Dr. Frederick J. Kaskel, MD, PhD here: Leave a Review
These charts describe general payments received by Dr. Frederick J. Kaskel, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$9,068
PROCYSBI $9,068 |
||||||
|
$5,979
TEPEZZA $4,646 |
PROCYSBI $1,333 |
|||||
|
$4,737
ACTHAR $4,737 |
||||||
|
$4,249
Filspari $315 |
$3,933 |
|||||
|
$3,267
NonCovered Product $3,267 |
||||||
|
$5,697
PROCYSBI $3,095 |
BMN044 $1,163 |
Cystaran $500 |
Lenvima $404 |
(815) Thiola $125 |
Other $410 |
| $14,838 | |
| $8,587 | |
| $5,141 | |
| $2,475 | |
| $1,955 |
Dr. Frederick J. Kaskel, MD, PhD has received 204 research payments totaling $237,876.
Frederick J Kaskel, MD, PhD, is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression.
